Amgen's (AMGN) OTEZLA Significantly Improved Measures Of Disease Severity In Adults With Mild-To-Moderate Plaque Psoriasis

Go back to Amgen's (AMGN) OTEZLA Significantly Improved Measures Of Disease Severity In Adults With Mild-To-Moderate Plaque Psoriasis
Amgen Inc (NASDAQ: AMGN) Delayed: 344.72 +7.12 (2.11%)
Previous Close $337.60    52 Week High $176.85 
Open $337.65    52 Week Low $133.64 
Day High $345.11    P/E 51.92 
Day Low $337.60    EPS $6.64 
Volume 2,520,731